We are a research biopharmaceutical company that develops and implements innovative medicines in areas with unmet medical needs.

The goal is to provide our patients with modern, affordable, highly effective drugs.

The mission - improving the quality and longevity of patients are paramount for us in the development of drugs.

We create - innovative molecules “First-in-Class, NME”, aimed at cytokines, chemokines, receptors, kinases, signal transduction pathways critical in the pathogenesis of autoimmune, immuno-inflammatory diseases, oncoimmunology.

Relevance - identifying the needs of patients and ahead of time, we create drugs for the treatment of difficult curable and incurable diseases.